ArticleBMC public health2025
Global lung cancer burden attributable to air fine particulate matter and tobacco smoke exposure: spatiotemporal patterns, sociodemographic characteristics, and transnational inequalities from 1990 to 2021.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Lifetime risk of respiratory system cancers across 185 countries: Global variation, socioeconomic inequalities, and ecological associations with air pollution.Preventive medicine reports · 2026Article
- Article
- Precision greenness exposure is associated with lung cancer risk in medicare beneficiaries.Cancer causes & control : CCC · 2026Article
- Temporal trends and forecasted mortality involving lung cancer with co-listed hypertension in U.S. adults, 2000-2035.Cardio-oncology (London, England) · 2026Article
- Identifying smoker subgroups with low readiness to quit: a cluster analysis of perceived lung cancer and asthma risk profiles.BMC public health · 2026Article
- Association between low fruit consumption and elevated lung cancer mortality: epidemiological evidence from the Global Burden of Disease Study 2021.European journal of nutrition · 2026Article
- Changes in premature mortality burden due to lung cancer attributable to tobacco exposure in rural southwest China: three repeated cross-sectional studies from 2013 to 2025.Archives of public health = Archives belges de sante publique · 2026Article
- Neglected Occupational Risk Factors-A Contributor to Diagnostic Delays in Lung Cancer.Healthcare (Basel, Switzerland) · 2026Article
- Article
- Sex-specific global burden of cardiometabolic and respiratory diseases attributable to secondhand smoke exposure: Insights from the global burden of disease study 2021.International journal of cardiology. Cardiovascular risk and prevention · 2025Article
- Silencing SOX2OT reduces viability and migration in lung cancer cells via lncRNA and protein regulation.Medical oncology (Northwood, London, England) · 2025Article
- Article
- ARID1A silencing-mediated upregulation of microRNA-652 accelerates cigarette smoke-induced human bronchial epithelial cell transformation by targeting ZFAND5.BMC pulmonary medicine · 2025Article
- Trends and projections of smoking-attributable lung cancer burden among the elderly in China, 1990-2021.American journal of cancer research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundAir fine particulate matter and tobacco smoke exposure are primary risk factors for lung cancer. However, their recent global exposure levels, attributable burden, and patterns of inequalities remain insufficiently quantified.
methodsUtilizing the Global Burden of Disease 2021 study, we analyzed exposure levels of air fine particulate matter (ambient and household) and tobacco smoke (active and secondhand) by age-standardized summary exposure value (ASEV). Age-standardized mortality rate (ASMR) and age-standardized disability-adjusted life years rate (ASDR) were used to assess their attributable lung cancer burden globally. Temporal patterns were examined using weighted average annual percentage change (WAPC). Cross-national health inequalities were evaluated with the concentration index (CI) for ASMR and slope index of inequality (SII) for ASDR.
resultsIn 2021, air fine particulate (PM2.5) exposure peaked in low socio-demographic index (SDI) countries, while tobacco exposure was highest in high-middle SDI regions. Globally, air PM2.5 contributed to 374.21 thousand (95% uncertainty interval [UI]: 236.36, 520.26) lung cancer deaths [ambient: 297.60 thousand (95% UI: 183.71, 414.74); household: 76.48 thousand (95% UI: 28.6, 187.34)], whereas tobacco exposure caused 1,238.65 thousand (95% UI: 1,075.69, 1,423.12) deaths [active smoking: 1,195.80 thousand (95% UI: 1,054.67, 1,359.22); secondhand smoke: 97.91 thousand (95% UI: 11.96, 184.91)]. High-middle SDI countries and the Southeast Asia, East Asia, and Oceania regions bore the greatest burden. The attributable burden for males exceeded that for females by approximately twofold for air PM2.5 and fivefold for tobacco exposure. The 55 + age group showed disproportionately high impacts despite lower exposure. From 1990 to 2021, the ASMR attributable to air PM2.5 and tobacco exposure changed annually by -1.32% (95% confidence interval [CI]: -1.48, -1.16) and - 0.95% (95% CI: -1.03, -0.88), respectively. The attributable ASDR also showed declining trends. Regarding translational health inequality, the air PM2.5 attributable lung cancer burden shifted from high to low SDI countries (CI: 0.05 to -0.10, SII: 31.00 to -35.50), while the tobacco-attributable burden persisted in higher SDI countries, albeit with diminishing inequalities (CI: 0.34 to 0.25, SII: 572.20 to 304.60).
conclusionsThis up-to-date study provides a comprehensive perspective on air fine particulate matter and tobacco smoke exposure's impact on lung cancer burden, highlighting its widespread nature, substantial impact, unequal distribution, and preventability. The findings call for targeted interventions and global cooperation across socioeconomic levels to reduce the overall lung cancer burden in the post-pandemic era.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.